MELISSA BEVINS: Open Payments
NPI 1144313172 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$169 in 7 payments from 6 companies in 2025. Trend: 2023 $89 · 2024 $243 · 2025 $169
Food & beverage: $169
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Calliditas Therapeutics US Inc. | 1 | $37 |
| Travere Therapeutics, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $23 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Fabhalta, TARPEYO, IBSRELA, Kerendia, FARXIGA.
Industry payments across NC — which companies pay providers there.
